SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-106937
Filing Date
2018-04-04
Accepted
2018-04-04 09:27:05
Documents
5
Period of Report
2018-04-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d562620d8k.htm 8-K 22630
2 EX-10.1 d562620dex101.htm EX-10.1 15309
3 EX-99.1 d562620dex991.htm EX-99.1 5657
4 GRAPHIC g562620g0403083842057.jpg GRAPHIC 2258
5 GRAPHIC g562620snap0001.jpg GRAPHIC 3159
  Complete submission text file 0001193125-18-106937.txt   52609
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 18735975
SIC: 2834 Pharmaceutical Preparations